Why movement and strength training matter during tirzepatide treatment
Tirzepatide supports substantial weight loss by acting on appetite regulatory pathways, making it easier to consume fewer calories [9]. In the pivotal SURMOUNT-1 clinical trial, 2539 adults with obesity or overweight achieved mean weight reductions between 15.0% and 20.9% across 5 mg, 10 mg, and 15 mg weekly doses over 72 weeks, compared to 3.1% in the placebo group [1]. However, that trial combined tirzepatide with lifestyle intervention [1]. The World Health Organization defines physical activity as any bodily movement produced by skeletal muscles requiring energy expenditure and notes that insufficiently active individuals face a 20% to 30% higher risk of death compared to sufficiently active adults [7]. In addition, NHS physical activity guidelines recommend at least 150 minutes of moderate activity weekly alongside muscle-strengthening exercises working all major muscle groups on at least 2 days each week [8]. When body weight drops rapidly, the body sheds both fat and fat-free tissue [2, 3]. Relying solely on calorie reduction without physical stimulus increases the proportion of lean tissue sacrificed, which can compromise long-term metabolic health and functional capacity [2, 6]. Resistance training provides mechanical stimulus that helps preserve lean tissue during weight loss [6]. Our guide on protecting muscle while losing weight covers general nutrition strategies in detail, while this article focuses on practical physical activity during tirzepatide treatment.
Read also: our guide on protecting muscle while losing weight
What lean-mass loss in trials shows and what it does not show
A major concern among patients starting tirzepatide is whether the medication directly wastes muscle tissue. Large tirzepatide trials focused primarily on overall weight change and cardiometabolic parameters [1]. Scientific reviews by Neeland and colleagues (2024) demonstrate significant heterogeneity across clinical trials of GLP-1-based therapies: reductions in lean mass vary widely, ranging from approximately 15% or less of total weight lost in some studies to 40% to 60% in others [2]. A critical physiological distinction emphasized by both Neeland et al. and Tinsley and Heymsfield (2024) is that fat-free mass is not synonymous with skeletal muscle [2, 3]. Fat-free mass encompasses water, internal organs, bone minerals, and the substantial fluid contained within adipose tissue itself [2, 3]. When substantial adipose tissue is lost, a corresponding portion of supportive cellular fluid and connective structure is inevitably reduced as an obligatory biological adaptation [3]. Magnetic resonance imaging investigations cited by Neeland et al. show that skeletal muscle volume reductions during GLP-1 therapy appear adaptive and commensurate with expected physiological adjustments to lower body mass, while muscle composition often improves through reduced fat infiltration and enhanced insulin sensitivity [2]. Skeletal muscle changes during GLP-1 therapy appear adaptive and commensurate with weight loss [2].
Clinical evidence for resistance exercise during dietary weight loss
Resistance training during dietary weight loss has been evaluated in systematic reviews [6]. A comprehensive systematic review and meta-analysis by Binmahfoz and colleagues (2025) synthesized data from 25 randomized controlled trials in adults aged 18 to 65 living with overweight or obesity [6]. The authors found that adding resistance exercise to dietary energy restriction had no significant effect on overall body mass reduction compared to diet alone, with a between-group difference of only -0.32 kg (p=0.35) [6]. Total weight loss across the included trials ranged from -2.5 kg to -20.9 kg in the resistance exercise groups and from -0.7 kg to -20.4 kg in the diet-only groups [6]. Crucially, however, the addition of resistance training protected against the loss of fat-free mass, demonstrating a statistically significant standardized mean difference of 0.40 (p=0.0003, moderate certainty evidence) [6]. Resistance exercise also significantly increased the loss of body fat mass, yielding a standardized mean difference of -0.36 (p < 0.00001, high certainty evidence) [6]. Furthermore, participants who engaged in resistance training achieved substantially greater muscular strength, with an effect size of 2.36 (p=0.00001) [6]. These findings align with NICE guideline NG246, which urges adults to increase physical activity regardless of scale changes for broad health benefits, noting that sustained daily activity of 60 to 90 minutes helps prevent weight regain after weight reduction [11].
The role of dietary protein alongside resistance training
Preserving functional lean tissue during pharmacologically induced calorie deficits requires combining mechanical resistance with sufficient dietary protein intake [3, 4]. A systematic review and meta-analysis by Kokura and colleagues (2024), encompassing 47 randomized controlled trials with 3218 adults living with overweight or obesity, evaluated enhanced protein intake during weight loss [4]. Across 28 trials involving 1989 participants that measured muscle mass, higher protein intake significantly prevented muscle mass decline compared to standard intake, showing a standardized mean difference of 0.75 (95% CI 0.41 to 1.10, p < 0.001) [4]. The authors reported that daily protein consumption exceeding 1.3 grams per kilogram of body weight was anticipated to increase or maintain muscle mass, whereas intakes below 1.0 g/kg/day were associated with a heightened risk of muscle loss [4]. Notably, Kokura et al. found that protein supplementation alone did not prevent declines in muscle strength or physical performance, underscoring that nutrition cannot replace physical training [4]. In healthy adults undertaking resistance training, a landmark meta-analysis of 49 trials by Morton and colleagues (2018) showed that protein supplementation enhanced one-repetition-maximum strength gains by 2.49 kg and fat-free mass by 0.30 kg [5]. Morton et al. identified a plateau breakpoint at approximately 1.62 g/kg/day, beyond which additional protein yielded no further resistance-induced gains in fat-free mass [5]. For tirzepatide users experiencing early satiety, practical clinic advice emphasizes spreading digestible protein sources across small meals throughout the day. Our guide on Mounjaro and bone health provides further recommendations on protecting skeletal density during rapid weight changes [5, 12].
Read also: our guide on Mounjaro and bone health
Managing fatigue, digestive symptoms, and injection schedules
Gastrointestinal side effects and transient lethargy are among the most frequently documented adverse events in clinical trials of tirzepatide [9, 12]. According to prescribing information, tirzepatide has an elimination half-life of approximately 5 days, resulting in sustained systemic levels across the weekly dosing interval [9, 12]. Mild to moderate nausea, vomiting, diarrhoea, constipation, and fatigue occur most prominently during the initial dose-escalation phase [1, 9, 12]. Both the Mounjaro and Zepbound labels explicitly warn healthcare providers and patients regarding the risk of acute kidney injury secondary to volume depletion caused by persistent vomiting or diarrhoea [9, 12]. Clinical practice requires adapting physical activity around individual tolerance during tirzepatide treatment. In our clinic we usually advise postponing high-intensity workouts on days when nausea is prominent. On those days we suggest gentle walking, light joint mobility, or seated stretching instead. Many patients tell us that exercising soon after a large meal makes nausea worse, so we usually advise a light meal and a comfortable gap before training. Maintaining steady hydration throughout the day is critical during tirzepatide treatment [9, 12]. Our review on Mounjaro and kidney health discusses hydration monitoring, lab evaluations, and clinical red flags in depth [9, 12].
Read also: our review on Mounjaro and kidney health
Resting heart rate, pacing by perceived effort, and starting from zero
Patients initiating tirzepatide may notice small cardiovascular adjustments [9, 12]. In pooled analyses of clinical trials, treatment with tirzepatide was associated with a mean increase in resting heart rate of 1 to 3 beats per minute in weight-management studies (Zepbound pool of Study 1 and 2) [9] and 2 to 4 beats per minute in placebo-controlled diabetes trials compared to 1 beat per minute with placebo [12]. The official prescribing information notes that the clinical relevance of this resting heart rate increase is uncertain [12]. Importantly, the trials report these observations specifically for resting pulse, and clinical guidance emphasizes pacing activity by how you feel rather than focusing anxiously on wrist monitors [8, 12]. The NHS recommends the practical "talk test" to gauge exercise intensity safely: during moderate aerobic activity, you should feel warm and breathe faster, being able to carry on a conversation comfortably but unable to sing [8]. When exercise becomes vigorous, breathing becomes rapid enough that you cannot speak more than a few words without pausing for breath [8]. Beginners can start with gentle home-based strength exercises [10]. NHS strength guidance outlines gentle bodyweight exercises that can be executed at home using a sturdy chair: sit-to-stand movements (5 repetitions), mini-squats holding the chair back for balance (5 repetitions), controlled calf raises (5 repetitions), sideways leg lifts (5 repetitions), straight-leg back extensions (5 repetitions holding for 5 seconds), wall press-ups (3 sets of 5 to 10 repetitions), and bicep curls using light handheld objects (3 sets of 5 repetitions) [10]. Practicing these movements twice weekly establishes muscular foundation safely [10].
Warning signs, safety limits, and when to seek medical evaluation
While physical movement offers substantial health advantages, safety requires recognizing clinical boundaries and stopping activity when warning symptoms appear [8, 12]. NHS physical activity guidelines advise that anyone who has been inactive, experiences chronic health conditions, or notices acute physical discomfort should consult a healthcare professional before progressing their exercise regimen [8]. Stop exercising and seek medical advice if you develop concerning symptoms such as chest pain or severe breathlessness [8]. Furthermore, prescribing information for tirzepatide outlines serious adverse risks that necessitate immediate medical intervention [9, 12]. Severe, persistent abdominal pain, which may radiate toward the back and is sometimes accompanied by vomiting, can indicate acute pancreatitis and mandates urgent assessment [9, 12]. Symptoms of gallbladder disease warrant clinical review [9, 12]. Dehydration and volume depletion can precipitate acute kidney injury during tirzepatide treatment [9, 12]. The risk of hypoglycaemia is higher when tirzepatide is combined with insulin or a sulfonylurea; dose adjustments may be needed [9, 12]. Patients should not adjust or stop prescribed medication without medical guidance [9, 12].
Medical follow-up and clinical nutrition at La Rose Clinics
Achieving sustainable weight loss while preserving strength and functional independence requires comprehensive medical oversight rather than unsupervised medication use [1, 9, 12]. At La Rose Clinics, individualized medical follow-up for weight management and GLP-1 receptor agonist therapy, including Mounjaro and Wegovy, is provided at our Maadi and Fifth Settlement branches [9, 12]. Clinical evaluations assess medical history, medication profiles, kidney parameters, and metabolic health before and during treatment [9, 12]. Accurate body composition tracking using InBody measurement is available in the clinic. Dr Alyaa Said Abu Taleb provides clinical nutrition and weight follow-up at the Maadi branch on Saturday and Monday from 2:00 pm to 7:00 pm. Dr Shimaa Fouad conducts nutrition and weight management follow-up at the Maadi branch on Saturday, Monday, and Tuesday from 3:00 pm to 8:00 pm, and at the Fifth Settlement branch on Wednesday from 3:30 pm to 8:00 pm. Please note that physiotherapy services are external: La Rose Clinics does not provide in-house physiotherapy, personal training, or athletic coaching. The Maadi clinic is located at 14 El-Mokhtar Street, off El-Nasr Street, behind QNB Bank, New Maadi. The Fifth Settlement clinic is situated in CMC Medical Mall, fourth floor, North 90th Street. If you experience severe symptoms such as intractable vomiting, profound dizziness, or reduced urination, seek urgent medical assessment [9, 12]. You can schedule your consultation through our clinic booking page to discuss your health history, medication plan, and physical activity safely [9, 12].
